Trials and tribulations of cytotoxic and targeted breast cancer therapy: a clinical perspective on the next phase of progress

Author： Twelves Chris  

Publisher： Informa Healthcare

ISSN： 1473-7140

Source： Expert Review of Anticancer Therapy, Vol.13, Iss.3, 2013-03, pp. : 251-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments

By Masui Kenta  

Carcinogenesis, Vol. 34, Iss. 4, 2013-04 ,pp. : 725-738

Oxford University Press

Access to resources Recommend Favorite

Monoclonal Antibody-Based Targeted Therapy in Breast Cancer

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 2, 2005-03 ,pp. : 99-106

Bentham Science Publishers

Access to resources Recommend Favorite

Molecularly Targeted Therapy in Breast Cancer: The New Generation

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 2, 2008-06 ,pp. : 100-104

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in systemic therapy for breast cancer: an overview and perspectives

By Piccart M.J.   Cardoso F.  

EJC Supplements, Vol. 1, Iss. 2, 2003-09 ,pp. : 56-69

Elsevier

Access to resources Recommend Favorite

Clinical Development of MET Targeted Therapy For Human Cancer

By  

Current Cancer Therapy Reviews, Vol. 5, Iss. 4, 2009-11 ,pp. : 261-270

Bentham Science Publishers

Access to resources Recommend Favorite